IRIS
LAULETTA, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.466
AS - Asia 2.156
EU - Europa 1.420
SA - Sud America 507
AF - Africa 80
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.366
SG - Singapore 963
CN - Cina 529
BR - Brasile 409
SE - Svezia 311
HK - Hong Kong 232
RU - Federazione Russa 193
IT - Italia 187
DE - Germania 164
FI - Finlandia 113
UA - Ucraina 112
VN - Vietnam 106
FR - Francia 105
GB - Regno Unito 101
IN - India 74
CA - Canada 51
AR - Argentina 40
BD - Bangladesh 36
TR - Turchia 35
MX - Messico 32
ID - Indonesia 30
IQ - Iraq 23
JP - Giappone 22
PL - Polonia 22
BE - Belgio 20
ES - Italia 20
ZA - Sudafrica 18
PK - Pakistan 17
NL - Olanda 16
CI - Costa d'Avorio 15
CO - Colombia 15
IE - Irlanda 15
MA - Marocco 13
SA - Arabia Saudita 13
UZ - Uzbekistan 12
AT - Austria 11
PH - Filippine 11
VE - Venezuela 11
JO - Giordania 8
LT - Lituania 8
MY - Malesia 8
CZ - Repubblica Ceca 7
NP - Nepal 7
PY - Paraguay 7
TN - Tunisia 7
BO - Bolivia 6
EC - Ecuador 6
EG - Egitto 6
AZ - Azerbaigian 5
CL - Cile 5
PA - Panama 5
BH - Bahrain 4
ET - Etiopia 4
KE - Kenya 4
LB - Libano 4
NI - Nicaragua 4
UY - Uruguay 4
DZ - Algeria 3
KR - Corea 3
MU - Mauritius 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
LY - Libia 2
OM - Oman 2
PE - Perù 2
TH - Thailandia 2
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 9.632
Salva come PNG Salva come JPEG
Città #
Fairfield 623
Ashburn 563
Singapore 532
Chandler 414
San Jose 398
Woodbridge 391
Seattle 254
Cambridge 252
Jacksonville 245
Houston 239
Nyköping 238
Hong Kong 231
Beijing 191
Wilmington 189
Ann Arbor 172
New York 93
Lauterbourg 80
Roxbury 76
Lawrence 73
Nanjing 70
Los Angeles 68
Dallas 65
Des Moines 53
Santa Clara 53
Bari 49
Helsinki 46
Princeton 46
Brooklyn 45
Boardman 40
Munich 38
Inglewood 37
São Paulo 33
San Diego 27
Buffalo 25
Ho Chi Minh City 25
Nanchang 24
Hebei 23
London 22
Tokyo 22
Brussels 20
Dong Ket 20
Shenyang 20
Toronto 20
Hanoi 19
Council Bluffs 18
Jakarta 18
Montreal 17
Falkenstein 16
Warsaw 16
Abidjan 15
Denver 15
Jiaxing 15
Dublin 14
Pune 14
Tianjin 14
Frankfurt am Main 13
Ankara 12
Belo Horizonte 12
Boston 12
Moscow 12
Orem 12
Phoenix 12
San Francisco 12
Tashkent 12
Columbus 11
Changsha 10
Chicago 10
Guangzhou 10
Jinan 10
Stockholm 10
The Dalles 10
Atlanta 9
Chennai 9
Grafing 9
Milan 9
Nuremberg 9
Paris 9
Amman 8
Baghdad 8
Guarulhos 8
Ostuni 8
Poplar 8
Rome 8
Shanghai 8
Casablanca 7
Charlotte 7
Haiphong 7
Johannesburg 7
Rio de Janeiro 7
Amsterdam 6
Brno 6
Curitiba 6
Dearborn 6
Elk Grove Village 6
Falls Church 6
Hounslow 6
Jeddah 6
Kuala Lumpur 6
Manaus 6
Medellín 6
Totale 6.727
Salva come PNG Salva come JPEG
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 211
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 201
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 196
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia 193
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 191
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 190
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 188
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 174
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 156
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 154
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 152
IN SITU SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS-RELATED ANTIGENS IN HEPATOCELLULAR CARCINOMA 149
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 149
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 147
Hepatitis C virus infection and mixed cryoglobulinemia 146
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 144
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 143
B-cell depletion in the treatment of mixed cryoglobulinemia. 143
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 134
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 133
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 133
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 133
Barrett's esophagus and esophageal cancer: An overview. 131
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 128
H. pylori infection and gastric cancer: state of the art (review). 127
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 126
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 124
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 122
null 122
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 119
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study 119
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 117
Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia 117
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 115
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 114
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 113
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 112
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 112
Antikörper gegen hepatitis-C-viren in humanen intravenösen immunoglobulinen. 108
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 108
REPLY TO THE LETTER TO THE EDITOR "ANDROGEN DEPRIVATION THERAPY AND RISK OF RHEUMATOID ARTHRITIS IN PATIENTS WITH LOCALIZED PROSTATE CANCER" by YANG et al. 108
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 104
A Challenging Case of Visceral Leishmaniasis 103
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 102
Assessment of total Hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. 102
Basi molecolari dell’associazione tra virus epatite e carcinoma epatocellulare 101
Crioglobulinemia mista e infezione da HCV 101
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 100
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 100
Cryoglobulinemic Vasculitis 100
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 100
null 96
Alcolizzazione percutanea del piccolo HCC. Casistica personale 94
Association Between Mixed Cryoglobulinemia, Translocation (14;18), and Persistence of Occult HCV Lymphoid Infection After Treatment 93
HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation 92
PEGYLATED INTERFERON-A, RIBAVIRIN AND RITUXIMAB COMBINED THERAPY OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA: A LONG-TERM STUDY 91
Cellule ematopoietiche staminali CD34+ e infezione cronica da virus C dell'epatite 91
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 90
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite con e senza crioglobulinemia mista 89
Vasculiti primarie sistemiche 87
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 86
In reply. Transarterial chemoembolization plus sorafenib... 83
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment 83
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 81
VIROLOGICAL ANALYSIS AND PHENOTIPIC CHARACTERIZATION OF PERIPHERAL BLOOD LYMPHOCYTES OF HEPATITIS C VIRUS-INFECTED PATIENTS WITH AND WITHOUT MIXED CRYOGLOBULINEMIA 79
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 79
T cell receptor variable beta gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia 79
null 78
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 75
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 75
Double filtration plasmapheresis in the treatment of leg ulcers in the course of type IHCV-positive cryoglobulinemia 74
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 69
Le tecniche di biologia molecolare nello studio dei tessuti fissati e paraffinati 68
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 66
ROLE OF THE RECEPTOR FOR THE GLOBULAR DOMAIN OF C1Q PROTEIN IN THE PATHOGENESIS OF CRYOGLOBULIN-RELATED VASCULAR DAMAGE 66
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 65
La vasculite crioglobulinemica: aspetti clinico-patogenetici 63
Natural interferon-Α versus its combination with 6-methyl prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term randomized, controlled study 63
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 61
null 61
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 59
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature 58
Immunodetection of hepatitis C virus (HCV)-related antigens in tissues: problems and perspectives 58
Serum IgM in type II mixed cryoglobulinemia recognize HCV E2 peptides 55
P87 MEDIASTINAL SYNDROME REVEALED HEART LOCALIZATION OF A PRIMARY MEDIASTINAL B-CELL LYMPHOMA 53
Cryoglobulinemia: the "cold" problem in cardiac surgery, a single-center experience and a literature review 51
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinemia 49
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements 49
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 48
null 47
Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study 46
Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation 45
Role of the receptor for the globular domain of C1q protein in the pathogenesis of HCV-related cryoglobulin vascular damage 44
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis. 43
Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia 41
Terapia della sindrome crioglobulinemica 33
Totale 9.871
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021253 0 0 0 0 0 0 0 0 0 129 68 56
2021/2022661 48 89 9 23 26 55 28 29 41 52 114 147
2022/20231.097 146 117 78 98 105 168 14 153 169 4 25 20
2023/2024380 33 77 16 25 34 93 20 19 4 8 4 47
2024/20251.595 35 25 131 44 31 147 200 140 58 79 235 470
2025/20262.918 475 158 156 331 401 196 436 80 435 250 0 0
Totale 9.871